FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969180545> ?p ?o ?g. }

• W2969180545 endingPage "172758" @default.
• W2969180545 startingPage "172758" @default.
• W2969180545 abstract "Acetylcholinergic (ACh) neurons interface with the mesolimbic dopamine pathway implicated in addiction, and acetylcholinesterase inhibitors (AChEis) have been shown to reduce the immediate effects of cocaine and amount used. Our study is the first to examine if the safe and low-interaction AChEi rivastigmine (riv) alters the subjective effects produced by cocaine administration. Cocaine-dependent subjects were randomized to daily placebo, riv 3 mg, or riv 6 mg, administered inpatient for 10 days. On day 1 (pre-dose) and day 9, subjects received both IV cocaine 40 mg or placebo in a randomized order with subsequent serial assessments of visual analog scale (VAS) subjective effects and pharmacokinetic measurements. On day 10 all participants received one baseline dose of cocaine 20 mg with assessment of subjective effects, and were then able to purchase additional doses at 15 min intervals with study earnings. 40 subjects were randomized to placebo (n = 16), riv 3 mg (n = 13), or riv 6 mg (n = 12). All subjects completed the study and there were no demographic differences between treatment groups. Pre- and post- treatment, there were no significant pharmacokinetic differences (blood levels of cocaine, BE, EME) following cocaine administration. In a two-way ANOVA, IV cocaine significantly increased positive VAS category ratings compared to placebo, but rivastigmine treatment at either dose had no significant effect on any VAS category ratings. Similarly, there was no significant rivastigmine effect on any category in the day 10 cocaine administration, and no effect on number of subsequent doses participants purchased. Rivastigmine 3 or 6 mg had no significant effect on the subjective effects of cocaine after 9 days of treatment. This is an important finding as other drugs in the AChEi class (donepezil, Huperzine A) have produced significant results, but differ in their receptor specificity and PK parameters." @default.
• W2969180545 created "2019-08-22" @default.
• W2969180545 creator A5026402806 @default.
• W2969180545 creator A5030381992 @default.
• W2969180545 creator A5031753699 @default.
• W2969180545 date "2019-10-01" @default.
• W2969180545 modified "2023-10-03" @default.
• W2969180545 title "Rivastigmine does not alter cocaine-induced subjective effects or self-administration" @default.
• W2969180545 cites W1494737704 @default.
• W2969180545 cites W1968359240 @default.
• W2969180545 cites W1986322740 @default.
• W2969180545 cites W1990473903 @default.
• W2969180545 cites W1998265688 @default.
• W2969180545 cites W1998674360 @default.
• W2969180545 cites W2000274215 @default.
• W2969180545 cites W2000983678 @default.
• W2969180545 cites W2002363647 @default.
• W2969180545 cites W2005026946 @default.
• W2969180545 cites W2008441751 @default.
• W2969180545 cites W2017472836 @default.
• W2969180545 cites W2025085189 @default.
• W2969180545 cites W2028638859 @default.
• W2969180545 cites W2030764226 @default.
• W2969180545 cites W2033282166 @default.
• W2969180545 cites W2035428955 @default.
• W2969180545 cites W2040212209 @default.
• W2969180545 cites W2052534327 @default.
• W2969180545 cites W2054798683 @default.
• W2969180545 cites W2056233657 @default.
• W2969180545 cites W2057870450 @default.
• W2969180545 cites W2061111736 @default.
• W2969180545 cites W2066254269 @default.
• W2969180545 cites W2072074091 @default.
• W2969180545 cites W2072267979 @default.
• W2969180545 cites W2074521340 @default.
• W2969180545 cites W2075305798 @default.
• W2969180545 cites W2092220167 @default.
• W2969180545 cites W2092899823 @default.
• W2969180545 cites W2105005652 @default.
• W2969180545 cites W2106185607 @default.
• W2969180545 cites W2140991283 @default.
• W2969180545 cites W2143813059 @default.
• W2969180545 cites W2154960645 @default.
• W2969180545 cites W2161047816 @default.
• W2969180545 cites W2165479128 @default.
• W2969180545 cites W2189665669 @default.
• W2969180545 cites W2287840130 @default.
• W2969180545 cites W2314526270 @default.
• W2969180545 cites W2607829808 @default.
• W2969180545 cites W2783328454 @default.
• W2969180545 cites W3151646759 @default.
• W2969180545 doi "https://doi.org/10.1016/j.pbb.2019.172758" @default.
• W2969180545 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31430484" @default.
• W2969180545 hasPublicationYear "2019" @default.
• W2969180545 type Work @default.
• W2969180545 sameAs 2969180545 @default.
• W2969180545 citedByCount "5" @default.
• W2969180545 countsByYear W29691805452021 @default.
• W2969180545 countsByYear W29691805452022 @default.
• W2969180545 crossrefType "journal-article" @default.
• W2969180545 hasAuthorship W2969180545A5026402806 @default.
• W2969180545 hasAuthorship W2969180545A5030381992 @default.
• W2969180545 hasAuthorship W2969180545A5031753699 @default.
• W2969180545 hasConcept C118552586 @default.
• W2969180545 hasConcept C126322002 @default.
• W2969180545 hasConcept C14184104 @default.
• W2969180545 hasConcept C142724271 @default.
• W2969180545 hasConcept C15744967 @default.
• W2969180545 hasConcept C168563851 @default.
• W2969180545 hasConcept C204787440 @default.
• W2969180545 hasConcept C27081682 @default.
• W2969180545 hasConcept C2776332859 @default.
• W2969180545 hasConcept C2778555786 @default.
• W2969180545 hasConcept C2779134260 @default.
• W2969180545 hasConcept C2779483572 @default.
• W2969180545 hasConcept C2779796075 @default.
• W2969180545 hasConcept C2780904820 @default.
• W2969180545 hasConcept C31896038 @default.
• W2969180545 hasConcept C42219234 @default.
• W2969180545 hasConcept C48856860 @default.
• W2969180545 hasConcept C71924100 @default.
• W2969180545 hasConcept C98274493 @default.
• W2969180545 hasConcept C99476002 @default.
• W2969180545 hasConceptScore W2969180545C118552586 @default.
• W2969180545 hasConceptScore W2969180545C126322002 @default.
• W2969180545 hasConceptScore W2969180545C14184104 @default.
• W2969180545 hasConceptScore W2969180545C142724271 @default.
• W2969180545 hasConceptScore W2969180545C15744967 @default.
• W2969180545 hasConceptScore W2969180545C168563851 @default.
• W2969180545 hasConceptScore W2969180545C204787440 @default.
• W2969180545 hasConceptScore W2969180545C27081682 @default.
• W2969180545 hasConceptScore W2969180545C2776332859 @default.
• W2969180545 hasConceptScore W2969180545C2778555786 @default.
• W2969180545 hasConceptScore W2969180545C2779134260 @default.
• W2969180545 hasConceptScore W2969180545C2779483572 @default.
• W2969180545 hasConceptScore W2969180545C2779796075 @default.
• W2969180545 hasConceptScore W2969180545C2780904820 @default.
• W2969180545 hasConceptScore W2969180545C31896038 @default.

• next